|
1
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
3
|
Milella M and Felici A: Biology of
metastatic renal cell carcinoma. J Cancer. 2:369–373. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009.PubMed/NCBI
|
|
5
|
Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy
SL, Breakefield XO and Skog J: Tumour microvesicles contain
retrotransposon elements and amplified oncogene sequences. Nat
Commun. 2:1802011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med (Berl). 91:431–437. 2013. View Article : Google Scholar
|
|
8
|
Yang L, Wu XH, Wang D, Luo CL and Chen LX:
Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis
and induce cell proliferation in vitro. Mol Med Rep. 8:1272–1278.
2013.PubMed/NCBI
|
|
9
|
Zhang Y, Luo CL, He BC, Zhang JM, Cheng G
and Wu XH: Exosomes derived from IL-12-anchored renal cancer cells
increase induction of specific antitumor response in vitro: A novel
vaccine for renal cell carcinoma. Int J Oncol. 36:133–140.
2010.
|
|
10
|
Weiss C, Schulze B, Ottinger A and Rödel
C: To combine or not combine: the role of radiotherapy and targeted
agents in the treatment for renal cell carcinoma. World J Urol. May
8–2013.(Epub ahead of print).
|
|
11
|
Coppin C, Kollmannsberger C, Le L,
Porzsolt F and Wilt TJ: Targeted therapy for advanced renal cell
cancer (RCC): a Cochrane systematic review of published randomised
trials. BJU Int. 108:1556–1563. 2011. View Article : Google Scholar
|
|
12
|
Yang C and Robbins PD: The roles of
tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol.
2011:8428492011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Samara GJ, Lawrence DM, Chiarelli CJ,
Valentino MD, Lyubsky S, Zucker S and Vaday GG: CXCR4-mediated
adhesion and MMP-9 secretion in head and neck squamous cell
carcinoma. Cancer Lett. 214:231–241. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu T, Wu Y, Helman JI, Wen Y, Wang C and
Li L: CXCR4 promotes oral squamous cell carcinoma migration and
invasion through inducing expression of MMP-9 and MMP-13 via the
ERK signaling pathway. Mol Cancer Res. 9:161–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park B, Sung B, Yadav VR, Cho SG, Liu M
and Aggarwal BB: Acetyl-11-keto-β-boswellic acid suppresses
invasion of pancreatic cancer cells through the downregulation of
CXCR4 chemokine receptor expression. Int J Cancer. 129:23–33.
2011.
|
|
16
|
Raman D, Baugher PJ, Thu YM and Richmond
A: Role of chemokines in tumor growth. Cancer Lett. 256:137–165.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar
|
|
18
|
Manu KA, Shanmugam MK, Rajendran P, Li F,
Ramachandran L, Hay HS, Kannaiyan R, Swamy SN, Vali S, Kapoor S, et
al: Plumbagin inhibits invasion and migration of breast and gastric
cancer cells by downregulating the expression of chemokine receptor
CXCR4. Mol Cancer. 10:1072011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Chen W, Gao L, Yang Q, Liu B, Wu
Z, Wang Y and Sun Y: High expression of CXCR4, CXCR7 and SDF-1
predicts poor survival in renal cell carcinoma. World J Surg Oncol.
10:2122012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gahan JC, Gosalbez M, Yates T, Young EE,
Escudero DO, Chi A, Garcia-Roig M, Satyanarayana R, Soloway MS,
Bird VG and Lokeshwar VB: Chemokine and chemokine receptor
expression in kidney tumors: molecular profiling of histological
subtypes and association with metastasis. J Urol. 187:827–833.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao M, Gao Y, Wang L, Liu S, Han B, Ma L,
Ling Y, Mao S and Wang X: Overexpression of integrin-linked kinase
promotes lung cancer cell migration and invasion via NF-κB-mediated
upregulation of matrix metalloproteinase-9. Int J Med Sci.
10:995–1002. 2013.
|
|
22
|
Jia W, Gao XJ, Zhang ZD, Yang ZX and Zhang
G: S100A4 silencing suppresses proliferation, angiogenesis and
invasion of thyroid cancer cells through downregulation of MMP-9
and VEGF. Eur Rev Med Pharmacol Sci. 17:1495–1508. 2013.
|
|
23
|
Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H,
Cheng YW, Lai LC and Chang YH: Human papillomavirus up-regulates
MMP-2 and MMP-9 expression and activity by inducing interleukin-8
in lung adenocarcinomas. PLoS One. 8:e544232013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dai ZJ, Wang BF, Lu WF, Wang ZD, Ma XB,
Min WL, Kang HF, Wang XJ and Wu WY: Total flavonoids of
Scutellaria barbata inhibit invasion of hepatocarcinoma via
MMP/TIMP in vitro. Molecules. 18:934–950. 2013.
|
|
25
|
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li
L, Yeh S and Chang C: Endothelial cells enhance prostate cancer
metastasis via IL-6→androgen receptor →TGF-β →MMP-9 signals. Mol
Cancer Ther. 12:1026–1037. 2013.PubMed/NCBI
|
|
26
|
Leifler KS, Svensson S, Abrahamsson A,
Bendrik C, Robertson J, Gauldie J, Olsson AK and Dabrosin C:
Inflammation induced by MMP-9 enhances tumor regression of
experimental breast cancer. J Immunol. 190:4420–4430. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
DI Carlo A: Evaluation of neutrophil
gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9
(MMP-9) and their complex MMP-9/NGAL in sera and urine of patients
with kidney tumors. Oncol Lett. 5:1677–1681. 2013.
|
|
28
|
Xue YJ, Xiao RH, Long DZ, Zou XF, Wang XN,
Zhang GX, Yuan YH, Wu GQ, Yang J, Wu YT, et al: Overexpression of
FoxM1 is associated with tumor progression in patients with clear
cell renal cell carcinoma. J Transl Med. 10:2002012. View Article : Google Scholar : PubMed/NCBI
|
